Wisconsin got a multi-state settlement from drug maker Astra-Zeneca for marketing an anti-psychotic drug which did not gain FDA approval. The said drug was aimed towards treating sleep problems such as insomnia and other psychiatric conditions.
Astra-Zeneca denied these claims and chose to settle the issue rather than let the drug issue get out of hand. At $4 million, that was indeed some issue which cost them a lot of dough!
Also see other interesting tags at SleepZine: astra zeneca, fda, fda approval, Insomnia, psychiatric conditions, psychotic drug, sleep, sleep problems, state settlement
